Intravenous thrombolysis with recombinant tissue plasminogen activator for ischemic stroke patients over 80 years old: the Fukuoka Stroke Registry
R Matsuo, M Kamouchi, H Fukuda, J Hata… - PLoS …, 2014 - journals.plos.org
Objectives The benefit of intravenous recombinant tissue plasminogen activator (rt-PA)
therapy for very old patients with acute ischemic stroke remains unclear. The aim of this …
therapy for very old patients with acute ischemic stroke remains unclear. The aim of this …
The safety and effectiveness of low-dose recombinant tissue plasminogen activator (0.6 mg/kg) therapy for elderly acute ischemic stroke patients (≥ 80 years old) in …
S Takayanagi, T Ochi, S Hanakita, Y Suzuki… - Neurologia medico …, 2014 - jstage.jst.go.jp
There are still few studies of low-dose recombinant tissue plasminogen activator (rtPA)
therapy (0.6 mg/kg) for acute ischemic stroke (AIS) patients≥ 80 years old, though most …
therapy (0.6 mg/kg) for acute ischemic stroke (AIS) patients≥ 80 years old, though most …
Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in J apanese older patients with acute ischemic stroke: F ukuoka S troke R egistry
R Matsuo, M Kamouchi, T Ago, J Hata… - Geriatrics & …, 2014 - Wiley Online Library
Aim The present study aimed to determine the efficacy and safety of thrombolytic therapy
with recombinant tissue plasminogen activator (rt‐PA) therapy in older patients compared …
with recombinant tissue plasminogen activator (rt‐PA) therapy in older patients compared …
Intravenous thrombolysis in Thai patients with acute ischemic stroke: role of aging
PA Dharmasaroja, S Muengtaweepongsa… - Journal of Stroke and …, 2013 - Elsevier
BACKGROUND: Intravenous thrombolysis is a standard treatment in eligible acute ischemic
stroke (AIS) patients. However, the advisability of treating patients> 80 years of age is still …
stroke (AIS) patients. However, the advisability of treating patients> 80 years of age is still …
Routine thrombolysis with intravenous tissue plasminogen activator in acute ischaemic stroke patients aged 80 years or older: a single centre experience
M Uyttenboogaart, EMC Schrijvers… - Age and …, 2007 - academic.oup.com
SIR—Treatment with intravenous tissue plasminogen activator (t-PA) in acute ischaemic
stroke has been shown to improve outcome [1]. Little is known regarding the safety and …
stroke has been shown to improve outcome [1]. Little is known regarding the safety and …
Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (≥ 80 years) stroke patients
J Berrouschot, J Röther, J Glahn, T Kucinski, J Fiehler… - Stroke, 2005 - Am Heart Assoc
Background and Purpose—Information on safety and efficacy of intravenous thrombolysis
with tissue plasminogen activator (tPA)(IV-tPA) in very old acute ischemic stroke (AIS) …
with tissue plasminogen activator (tPA)(IV-tPA) in very old acute ischemic stroke (AIS) …
[HTML][HTML] Intravenous tissue plasminogen activator improves the outcome in very elderly Korean patients with acute ischemic stroke
Background and Purpose In a recent pooled analysis of randomized clinical trials (RCTs),
intravenous tissue plasminogen activator (TPA) improves the outcome in patients aged≥ 80 …
intravenous tissue plasminogen activator (TPA) improves the outcome in patients aged≥ 80 …
[PDF][PDF] Safety and effectiveness of intravenous thrombolysis with recombinant tissue plasminogen activator in eighty years and older acute ischemic stroke patients
Y Chen, CH Li, YX Wang, CH Zhang… - Eur Rev Med …, 2015 - europeanreview.org
OBJECTIVE: To explore the safe-ty and efficacy of intravenous thrombolysis (IVT) with
recombinant tissue plasminogen activator (rt-PA) in elderly (≥ 80 years old) acute ischemic …
recombinant tissue plasminogen activator (rt-PA) in elderly (≥ 80 years old) acute ischemic …
Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study
Background: The benefit of intravenous tissue plasminogen activator (tPA) given within 3 h
of acute ischaemic stroke to patients over 80 years of age is uncertain. Aim: To examine the …
of acute ischaemic stroke to patients over 80 years of age is uncertain. Aim: To examine the …
Thrombolysis for acute ischemic stroke patients aged 80 years and older: Canadian Alteplase for Stroke Effectiveness Study
Background: The benefit of intravenous tissue plasminogen activator (tPA) administered
within 3 hours of acute ischemic stroke in elderly patients is uncertain. We sought to …
within 3 hours of acute ischemic stroke in elderly patients is uncertain. We sought to …